Daiichi Sankyo names Markus Kosch head of Europe business

Daiichi Sankyo appoints Markus Kosch to lead its European business from April 2027 and combines Oncology and Specialty in a new structure.

Quanterix appoints Jim Gute as Chief Commercial Officer

Quanterix has named Jim Gute Chief Commercial Officer, tasking him with leading commercial growth across biomarker testing and diagnostics.

BARMER CEO Christoph Straub to step down at the end of 2026

Christoph Straub will step down as BARMER’s board chairman at the end of 2026. Simone Schwering and Uwe Repschläger will follow.

Simon Goeller to lead Sandoz in Germany

Sandoz has appointed Dr. Simon Goeller as Country President in Germany. He also takes on the CEO role at Hexal.

Katrin Neuffer takes over investor relations and communications at Medios

Medios appoints Katrin Neuffer as Director Investor Relations & Communications. She succeeds Claudia Nickolaus in the capital markets role.

BioNTech names Guido Oelkers as next CEO

BioNTech has appointed Guido Oelkers to its Management Board. The Sobi CEO is set to succeed Ugur Sahin by February 2027.

Sarepta appoints Michael Severino as CEO

Sarepta Therapeutics appoints Michael Severino as CEO. Doug Ingram will retire and support the transition through the end of 2026.

Legend Biotech names Alan Bash interim CEO

Ying Huang has stepped down as Legend Biotech CEO and board member. Alan Bash will lead the cell therapy company on an interim basis.

Carsten Linnemann set to become health minister

Carsten Linnemann is set to take over Germany’s health ministry, while Nina Warken is expected to move to the Chancellery.

Mediengruppe DAV reorganizes management board

Mediengruppe Deutscher Apotheker Verlag is reorganizing its management board in response to changes in its market environment.

Convatec CFO Fiona Ryder to step down, Tobias Hestler joins board

Convatec is preparing a CFO change. Fiona Ryder will remain until a successor is appointed, while Tobias Hestler joins the board.

Sanofi reshapes Executive Committee

Sanofi will reshape its Executive Committee on September 1, 2026, with changes across R&D, business units, finance and regional roles.

Tarsus names Neera Clase interim Chief Commercial Officer

Tarsus Pharmaceuticals says CCO Aziz Mottiwala will depart, with Neera Clase taking over the commercial role on an interim basis.

COMPRIX advisory board appoints Christoph Bohlender

Christoph Bohlender of MENSCH Kreativagentur joins the COMPRIX advisory board as Dr. Giuseppe Gianni of Brand Health steps down.

Holger Holakovsky takes the lead in Dortmund

Holger Holakovsky has taken over the lead at Boehringer Ingelheim microParts in Dortmund as Simone Schulz moves to a global role.

NOWEDA: Udo Harneit to succeed Dr. Michael Kuck

NOWEDA CEO Dr. Michael Kuck will retire at the end of 2026. Sales board member Udo Harneit is set to take over in January 2027.

Tatjana Dreyer takes communications role at Novartis Germany

Tatjana Dreyer has joined Novartis Germany to lead communications and patient advocacy, adding the role to the Country Leadership Team.

Christiane Steur to head Boehringer’s Biberach site

Christiane Steur has taken over leadership of Boehringer Ingelheim’s Biberach site, succeeding long-standing site head Thomas Reith.

Rentschler Biopharma names Torsten Wöhr CEO

Rentschler Biopharma has appointed Torsten Wöhr as CEO. The CDMO executive will take over from interim CEO Uwe Bücheler on August 1, 2026.

Vetter highlights career entry routes in the pharmaceutical industry

Vetter uses the TALENT Talks career podcast to discuss internships, training and development options for young pharma talent.